key: cord-1039682-m57mkjdr authors: Chen, Xiahui; Kang, Shoukai; Ikbal, Ashif; Zhao, Zhi; Pan, Yuxin; Zuo, Jiawei; Gu, Liangcai; Wang, Chao title: Synthetic Nanobody-Functionalized Nanoparticles for Accelerated Development of Rapid, Accessible Detection of Viral Antigens date: 2021-09-30 journal: bioRxiv DOI: 10.1101/2021.05.09.443341 sha: 1be52d0af1f57b38c75ab6b3f02bb6302ba9dd3e doc_id: 1039682 cord_uid: m57mkjdr Successful control of emerging infectious diseases requires accelerated development of fast, affordable, and accessible assays to be widely implemented at a high frequency. Here we present a generalizable assay platform, nanobody-functionalized nanoparticles for rapid, electronic detection (Nano2RED), demonstrated in the detection of Ebola and COVID-19 antigens. To efficiently generate high-quality affinity reagents, synthetic nanobody co-binders and mono-binders with high affinity, specificity, and stability were selected by phage display screening of a vastly diverse, rationally randomized combinatorial library, bacterially expressed and site-specifically conjugated to gold nanoparticles (AuNPs) as multivalent in-solution sensors. Without requiring fluorescent labelling, washing, or enzymatic amplification, these AuNPs reliably transduce antigen binding signals upon mixing into physical AuNP aggregation and sedimentation processes, displaying antigen-dependent optical extinction readily detectable by spectrometry or simple electronic circuitry. With nanobodies against an Ebola virus secreted glycoprotein (sGP) and a SARS-CoV-2 spike protein receptor binding domain (RBD) as targets, Nano2RED showed a high sensitivity (limit of detection of ∼10 pg/mL for sGP and ∼40 pg/mL for RBD in diluted human serum), a high specificity, and a large dynamic range (∼7 logs). Unlike conventional assays where slow mass transport for surface binding limits the assay time, Nano2RED features fast antigen diffusion at micrometer scale, and can be accelerated to deliver results within a few minutes. The rapid detection, low material cost (estimated < $0.01 per test), inexpensive and portable readout system (< $5 and < 100 cm3), and digital data output, make Nano2RED particularly suitable for screening of patient samples with simplified operation and accelerated data transmission. Our method is widely applicable for prototyping diagnostic assays for other antigens from new emerging viruses. In recent times, we have witnessed the emergence of many infectious viral diseases, from the highly fatal Ebola virus disease (EVD, with a fatality rate of 45% to 90%) 1, 2 to the highly contagious coronavirus disease 2019 (COVID- 19) with its global >200 million infections and >4 million deaths as of August 2021 3 . Future emergence of Disease X, as contagious as and as lethal as EVD, would pose an even greater threat to humanity, and will be both difficult to prevent or predict. During disease emergence, early pathogen identification and infection isolation are extremely critical for containing disease transmission 4 . Therefore, for effective mitigation, it is necessary to accelerate the design, development, and validation of diagnostic processes, as well as to make the diagnostic tools broadly accessible within weeks of the initial outbreak 4 . Current diagnostic methods rely on the detection of the genetic (or molecular), antigenic, or serological (antibody) markers 5 . Genetic diagnostics use DNA sequencing, polymerase amplification assays, or most recently, CRISPR technologies 6, 7 . For example, real-time reverse transcription polymerase chain reaction (RT-PCR) tests are viewed as the gold standard for their high sensitivity; however, these tests are also costly, time-consuming, and instrument-heavy. Genetic tests also can often display false positives by picking up genetic fragments from inactive viruses 8 . In comparison, antigen and antibody detections are complementary as they allow more rapid, affordable, and accessible detection without complex sample preparation or amplification. As such, these detection methods are viewed as suitable for surveillance and timely isolation of highly infectious individuals, particularly outside clinical settings 8 . While antibody (e.g., IgM) detection has been used for disease diagnostics 9 , it is less predictive and more suitable for immune response studies. In comparison, viral protein antigen tests provide a reliable field-test solution in diagnosing symptomatic patients [9] [10] [11] , and may serve to screen asymptomatic contacts that may become symptomatic 12 . In addition, since they are rapid, easy to operate, and low-cost, antigen tests can be deployed at high frequencies and large volumes for in-time surveillance, which is thought to be the most important factor in disrupting a virus transmission chain 8, 12 . Current antigen diagnostics typically employ enzyme-linked immunosorbent assays (ELISA) and lateral flow immunoassays (LFIs). ELISA is the workhorse for analyzing antigens and antibodies, but it requires a multistep workflow and a series of washing steps, hours of incubation prior to readout, and a readout system dependent on substrate conversion and luminescence recording. Deployment of ELISAs in high-throughput mass screenings requires automated liquid handling systems to coordinate the complex workflow, which is not ideal for portable uses. LFIs are potentially much easier to use outside lab settings but usually have much lower sensitivity and thus poorer accuracy compared to ELISA 13 . Here we report a modular strategy, i.e., nanobody-conjugated nanoparticles for rapid electronic detection (Nano2RED), which can quickly establish a rapid, accessible antigen diagnostic tool within a few weeks of pathogen identification. To generate high-quality affinity reagents within two weeks for any given purified marker protein, we have streamlined a protocol for phage selection of single-domain antibodies (or nanobodies) 14 from a highly diverse combinatorial library (> 10 9 ) and bacterial expression of top hits with a significantly faster turnaround time and a lower cost than mammalian expression. Unlike traditional antibodies requiring non-specific conjugation to any solid support, potentially resulting in loss of function, nanobodies were genetically fused with an AviTag for site-specific biotinylation and immobilization onto streptavidin-coated gold nanoparticles (AuNPs). These nanobody-functionalized AuNPs serve as multivalent antigen binding sensors in our Nano2RED assays for Ebola and COVID-19 antigen detection. Based on only physical processes, including plasmonic NP color display, NP precipitation, and semiconductor photon absorption, Nano2RED quantitatively transduces antigen binding into colorimetric, spectrometric, and electronic readouts ( Figure. 1 ). Without fluorescent labeling or chemiluminescent readout, Nano2RED differs fundamentally from conventional highsensitivity tests (e.g., genetic tests or ELISA) that are generally expensive and more suitable for lab use. Yet, Nano2RED greatly outperforms conventional portable and low-cost tests (e.g., LFIs), which are not qualitative or sensitive enough. Uniquely, Nano2RED features portability, low cost, and simplicity while preserving a high sensitivity (LOD of ~ 0.13 pM or 11 pg/mL in Ebola sGP sensing), a high specificity (distinguishing sGP from its membrane-anchored isoform GP1,2) and a large dynamic range (~7 logs). Additionally, its electronic readout capability can be extended to automate data collection, storage, and analysis, further reducing the workload health care workers, and speeding up diagnostic and surveillance response. We generated nanobody co-binders (i.e., two mono-binders simultaneously binding to nonoverlapping epitopes in the same antigen) against target antigens for a new in-solution assay to improve the sensitivity and specificity (Figure 1a ). Traditional methods for selecting antibodybased co-binders are slow and costly, so here we established a fast, robust protocol including the phage display selection of the combinatorial nanobody library, parallel bacterial protein production, co-binder validation, and AuNP functionalization that can be completed in less than two weeks upon the availability of an antigen protein ( Figure 2a) . Nanobodies, a single-domain (12-15 kDa) functional antibody fragments from camelid comprising a universal scaffold and three variable complementarity-determining regions, are ideally suited for phage display selection and low-cost bacterial production 14 . To avoid relatively lengthy and costly procedures and animal protection issues associated with traditional antibody screening, we screened the synthetic nanobodies library with an optimized thermostable scaffold prepared in our previous work 15 . The Ebola antigen, sGP, is a homodimeric isoform of the glycoproteins encoded by a GP gene of all five species of Ebolavirus with multiple post-translational modificiations 16 . sGP is believed to act as a decoy to disrupt the host immune system by absorbing anti-GP antibodies 16, 17 . Given its abundance in the blood stream upon infection and its quantitative correlation with disease progression and humoral response, sGP is widely used as a circulating biomarker in EBOV diagnostics 17, 18 . The chosen SARS-CoV-2 antigen, RBD, engages the viral receptor, human angiotensin-converting enzyme 2 (ACE2), causing conformational changes that trigger a cleavage needed for viral infection 19, 20 . It is a major antigenic target for protective antibodies 21 , and thus is highly significant for diagnostics, as well as for the development of vaccines and therapeutic neutralizing antibodies 22, 23 . To efficiently identify nanobodies that can bind non-overlapping epitopes of an antigen protein, we assessed clonal diversity and co-binding abilities of candidates enriched in different biopanning rounds. The antigens, sGP (ManoRiver) and RBD (residues 328-531), were expressed as AviTag fusions in HEK293 and biotinylated for immobilization on streptavidin-coated magnetic beads. We identified three co-binder pairs from 10 unique nanobodies out of 96 randomly picked clones that specifically bind to sGP after three rounds of biopanning. For the RBD with a relatively smaller size (~30 kDa), we identified two co-binder pairs from 12 unique binders after the first round ( Figure 2b ). The two top co-binder pairs, termed sGP7-sGP49 and RBD8-RBD10, were bacterially expressed and purified (Figure 2c and Figure S1a Lastly, nanobodies were biotinylated with E. coli biotin ligase (BirA) as previously reported 15 and then loaded to streptavidin-coated AuNPs (see Methods section). In our assay design, AuNPs densely coated with biotinylated nanobodies allow multivalent antigen sensing (Figure 1a and 1b) known to significantly enhance antigen binding compared to the monovalent binding 24, 25 . Further, the multivalent binding also facilitates AuNP aggregation at the presence of the antigen and subsequent precipitation, producing antigen-concentrationdependent signals within minutes. The AuNP aggregation is further quantified by optical and electronic measures. In our proposed sensing scheme (Figure 1b) , AuNPs, without nonspecific particle-particle interaction, are initially homogenously dispersed in colloid, presenting a reddish color from characteristic localized surface plasmon resonance (LSPR) extinction 26 . Upon mixing with viral antigens, multiple AuNPs are pulled together by the antigen-nanobody binding to gradually form large aggregates. Compared to a single AuNP, the formation of AuNP aggregates gradually shifts LSPR extinction to higher wavelengths with broadened resonance attributed to plasmonic coupling between AuNPs 27, 28 , a phenomenon that can be simulated by finite-difference time-domain (FDTD) method (Supplementary section 2 and Figure S2 ). This leads to increased transparency of the AuNP colloid preciously described in DNA and protein sensing applications 29, 30 . Large AuNP aggregates can form pellets as gravity overtakes the fluidic drag force (Figure 1c (Figure 1d ). The color change can be directly visualized by eye, and quantified in a well plate by spectrophotometer or using a simple electronic device that measures the AuNP extinction. The size and shape of AuNPs determine the optical extinction and therefore the suspension color, hence affecting the sensitivity and assay incubation time ( Figures S3 and S4) . Here, the AuNP size effect was studied with NP diameters of 40, 60, 80, and 100 nm in sensing of Ebola sGP proteins using sGP49 nanobody in 1× phosphate buffered saline (PBS) buffer (Supplementary section 3). To standardize the measurement, the sGP signals were collected using a UV-visible spectrometer coupled to an upright microscope ( Figure S3a ). We custom-designed a polydimethylsiloxane (PDMS) well plate bonded to glass slides as the sample cuvette ( Figure S3b ). Top-level liquid from sGP sensing samples (5 μL) after incubation were loaded and inspected by optical imaging and spectroscopy readout. Clearly, as evidenced in the optical images ( Figure S4 a-d), the color of the assay is redder for small NPs but greener for larger ones, which is attributed to a redshift in extinction resonance wavelengths at larger NP sizes. Additionally, a significant color contrast was observed in distinguishing 10 nM and higher sGP concentration from the reference negative control (NC) sample (with only PBS buffer but no sGP) for all AuNP sizes, indicating that sGP can be readily detected by the naked eye. Such colorimetric diagnostics would be very useful for qualitative or semi-quantitative diagnostics in resource-limited settings, but less ideal for quantitative and ultrasensitive detection. Additional accurate sGP detection was performed by quantifying the AuNP extinction signals in the PDMS plate using our spectroscopic system ( Figure S4 e-l) . The AuNP extinction is correlated with its concentration and diameter following ∝ 31 . A decrease of extinction indicated a drop of in the upper liquid level caused by antigen-induced AuNP precipitation. Further, the AuNP extinction peak values were extracted and plotted as standard curves against the sGP concentration at each AuNP size ( Figure S4 i-l) . This incubation-based assay had a large dynamic range of ~100 pM to ~100 nM for all AuNP sizes. In addition, the incubation was found to take 4 to 7 hours, using 40 to 100 nm NPs for detecting 10 nM sGP in 1× PBS ( Figure S4 m-p) . This NP size-dependent response could be understood intuitively from the antigen binding dynamics and the AuNP precipitation process. On the one hand, smaller NPs had higher starting concentrations, given that in our design the starting suspension extinction ∝ was about the same for all sizes, and therefore were expected to initiate the antigenbinding and NP aggregation reaction relatively faster. On the other hand, the precipitation of smaller aggregates took a longer time, resulting in a longer incubation period. From these experimental analyses in 1× PBS buffer, we chose 80 nm AuNPs to further characterize the assay performance in sGP sensing ( Figure 3a ). This selection was based on several factors: their slightly higher sensitivity (~15 pM, compared to ~100 pM for other sizes), larger detection dynamic range (up to 4 logs, compared to 2 to 3 logs for other sizes), and shorter incubation time (3 to 4 hours, compared to 4 to 7 hours for other sizes). To understand the assay's working mechanism, we complemented the solution-phase optical Figure S5 ). This supports our sensing mechanism in that AuNP precipitation serves to transduce antigen binding to solution color change for sensing readout ( Figure 1 ). Further, we have performed dropcasting to deposit AuNP upper-level liquid samples on glass slides for optical extinction analysis ( Figures S6 and S7 ) and on gold films for scanning electron microscopy (SEM) and dark field scattering imaging ( Figures S8, S9 , and S10). The measurement results were, in general, consistent with spectrometric in-solution sGP detection using PDMS well plate, but inferior in sensitivity (150 pM for SEM, ~174 pM for drop-cast on glass slide, and ~1 nM for dark filed imaging, Table 1 ). The decreased sensitivity could be attributed to inherent variations associated with sample preparation and background noise in the readout systems. These solid-state characterization methods were non-ideal for accessible and precise detection, given the low sensitivity and need of lab instrument for readout, but they provided valuable insight into the nano-scale NP aggregation process. sGP was further detected in diluted fetal bovine serum (FBS, 5%) using 80 nm sGP49- nM, which supports clinically relevant Ebola detection from patients' blood (sub-nM to µM) 32, 33 . Here the three-sigma limit of detection (LoD), defined as the concentration displaying an extinction differentiable from the NC sample ( ), or 3 where is the measurement variation of all samples, was found to be about 15 pM (or 1.25 ng/mL), comparable to that measured using sGP49 phage ELISA (LOD estimated ~80 pM, Figure 3g and supplementary Table S1 ). The LOD can be understood from simple and rough estimations based on the nature of multivalent antigen binding (supplementary section 5). We also found the 10 nM sGP could be easily distinguished from NC sample at a broad temperature range from 20 to 70°C (Figure 3h ). This indicates our assay can be transported, stored, and tested at ambient temperatures without serious concerns of performance degradation, which is very important for mass screening. The PDMS well plate-based spectrometric measurement required about 3 hours incubation for effective AuNP bridging and precipitation, which is shorter than ELISA and much better than many RT-PCR assays. However, rapid diagnostics, that is, less than 30 minutes, is more desirable for accessible infectious disease diagnosis and control of disease spread. Here, we further studied the sensing mechanism, aiming to reduce the detection time (Supplementary section 6.1). In conventional ELISA assays, the antigen diffusion process is usually the rate-limiting step 34 35 . Briefly, an empirical parameter P, which defines the probability of antigen-nanobody binding per collision, has a large impact on the modelled assay time. By comparing to experimentally measured assay incubation time, we found using P=1, that is very high-affinity binding, provides a much better prediction compared to using a smaller P value calculated by the ELISA-measured kinetic constants. This observation is attributed to two factors: the ELISA-measured binding kinetics is strongly affected by the surface-limited diffusion process and could not precisely estimate the true nanobody-antigen binding in solution 36, 37 ; and the multivalence of the nanobody-bound AuNPs greatly improves the observed "functional affinity" compared to intrinsic mono-binding affinity 24, 25 (~80 pM) compared to incubation. Using 10 nM sGP as the antigen, we found the color contrast was high enough to be immediately resolved by the naked eye after vortex mixing, requiring minimal incubation (Figure 5h and S11a). Including all of the operation steps for sample collection, pipetting, centrifugation, vortex mixing, and readout, this rapid test scheme can be completed in a few minutes. Extinction spectrometric analysis provides quantitative and accurate diagnostics but requires bulky spectrometer systems that are more suitable for lab use. We demonstrated the feasibility of detecting sGP in FBS using a cost-efficient, portable UV-visible spectrometer system for field deployment ( Figure S13 ). Additionally, we developed a homemade LED-photodiode based electronic readout system with significantly reduced system cost to deliver accurate and sensitive detection results comparable to a lab-based spectrometer system ( Figure 4 i-k) . Here, an LED light source emitted narrowband light at the AuNP extinction peak ( 560 nm, = 40 nm), which transmitted through the upper-level assay liquid and then was collected by a photodiode (Figure 4i ). As a result, a photocurrent or photovoltage was generated on a serially connected load resistor in a simple circuitry that can be easily integrated and scalably produced. In practice, we 3D-printed a black holder to snug-fit a microcentrifuge tube, and mounted the LED and photodetector on two sides of the holder (Figure 4j ). The LED and photodiode were powered by alkaline batteries (3V and 4.5V, respectively), and the bias voltages were set to ensure wide-range detection of sGP proteins without saturating the photodetectors. Using 80 nm sGP49functionalized AuNP Nano2RED assays, sGP was detected in diluted FBS (5%) by reading the photovoltage signals with a handheld multimeter (Figure 5k , , in black). Compared to lab-based spectrometric readout (in blue), the electronic readout displayed identical dynamic range, but slightly improved LOD (27 pM compared to 80 pM). We further evaluated the use of co-binding nanobodies in sGP and RBD sensing ( Supplementary Tables S1 and S2. There are several notable observations. First, using sGP sensing as an example and comparing to previously reported results 18, 39 (Supplementary Table S2 ), Nano2RED with spectrometric and electronic readout consistently produced ~130 fM to 1.3 pM LOD (or ~10 to ~100 pg/mL) in PBS, FBS, and HPS. It is noted that a very recently reported cobinder-based D4 assay format reported ~30 pg/mL LOD in human serum, and was able to detect the Ebola virus earlier than PCR in a monkey model 18 . In LOD comparison, the sensitivity of Nano2RED (~10 pg/mL with electronic readout) is even better, indicating its competitiveness in high-precision diagnostics. Additionally, our study (Table 1 ) also revealed the importance of a systematic assay design strategy, from molecular binding to signal transduction and readout, to optimize antigen detection. It is clear that the co-binder pair improved the LOD by 10 to 100 times compared to the monobinder (sGP49, 4.6 nM), despite a relatively low of 199 nM for the second binder (sGP7) ( Figure 2 ). This improved sensitivity is likely because the co-binders have a favorable, noncompetitive binding configuration that serves to improve antigen binding and AuNP aggregation. Uniquely, the use of a portable and inexpensive electronic readout did not negatively affect the LOD of Nano2RED, but rather improved it compared to spectrometric readout (Figures 5i and 6i, and Table 1 and 2). This can be attributed to smaller 3-sigma errors in the electronic readout (Supplementary Table S2) , partly due to a larger signal fluctuation in optical imaging caused by manual operation, such as in focusing. Here, the electronic signal is mainly dependent on the circuit elements but much less dependent on operators' judgement, and thus potentially more reliable and accurate. In addition, the use of biological buffers could also affect detection. For both Ebola sGP and SARS-CoV-2 RBD, the LOD increased by about 5-10 times in serum (FBS and HPS) than in PBS, and further increased by another 10 times in WB. Additionally, the colorimetric readout by the naked eye was capable of detecting both antigens in serum at concentrations higher than 100 pM or 1 nM (Figures 5 and 6) ; however, it became challenging to do so in WB, mainly due to the fact that WB absorbs in short wavelengths and causes background color interference with AuNPs ( Figures 5 j-k) . However, the spectrometric readout could still readily identify the sGP or RBD extinction signals from the background WB absorption for accurate detection ( Figure S19e and Figure 5l for sGP and Figure S25 e and Figure 6l for RBD), indicating the feasibility of Nano2RED for field use with minimized sample preparation. Fundamentally different from conventional high-sensitivity antigen diagnostics that usually require bulky and expensive readout systems, as well as long assay time, Nano2RED is an affordable and accessible diagnostic technology. For example, ultrasensitive sGP sensing using NP-enhanced fluorescent readout would require 3-4 hours of image processing to reduce noise for optimal sensing 39 , and these fluorescent systems usually require cubic meter space and cost $40,000 or more (a high-end fluorescent camera with high signal-to-noise ratio is ~$25,000). Similarly, a D4 co-binder assay requires a lab-based bulky fluorescent system and ~60 min assay time to achieve PCR-comparable diagnostic sensitivity. Its sensing performance drops ~10 times to 100 pg/mL when using a customized fluorescent system, which costs ~$1,000 and occupies ~3,000 cm 3 . The performance further decreases to 6,000 pg/mL when using LFA with colorimetric readout 18 . Clearly standing apart from the rest, Nano2RED utilizes miniaturized and low-cost semiconductor devices for signal readout rather than a fluorescent system. Therefore, it has a very small footprint (4 cm 3 for tube holder, or <100 cm 3 for the whole system, including batteries and meters, which all could be miniaturized on a compact circuit board in the future), is very low cost (LED and photodiode each <$1 here, but can be <$0.1 when used at large scale, with the total system cost estimated well below $5), and offers a rapid readout (5 to 20 min, depending on incubation time after centrifugation). Further, the electronic readout is more accurate than the colorimetric readout, more accessible, without color vision limitations, and more readily available for data storage in computers or online databases for real-time or retrospective data analysis. Additionally, we have estimated the reagent cost in Nano2RED is only about $0.01 per test (Supplementary section 9), since it requires only a small volume (~20 µL) of regents. We tested sGP against GP1,2, a homotrimer glycoprotein transcribed from the same GP gene and sharing its first 295 residues with sGP 16 , both in FBS (Figures 5 d-f and m-o) . The majority of GP1,2 can be found on virus membranes whereas a small portion is released into the patient's bloodstream. The close relevance of GP1,2 to sGP makes it a very strong control molecule to assess our assay's specificity. Indeed, GP1,2 did not produce detectable signals unless higher than 1 nM, indicating a high selectivity over a broad concentration range (100 fM to 1 nM, or 4 logs) where minimal nanobody binding or AuNP aggregation occurred. A high assay specificity is crucial for minimizing false positive diagnosis of infectious diseases, which could lead to unnecessary hospitalizations and even infections. Considering that 10 nM and higher sGP concentration is typical for EVD patients 32, 33, 40 , Nano2RED is particularly suitable for high-speed mass screening of EVD susceptible populations. Further, SARS-CoV-2 RBD proteins were also detected in the single-digit picomolar range in PBS, FBS, and HPS, with the best LOD ( pg/mL) again achieved with electronic readout. The LOD in RBD sensing is ~10 times higher compared to sGP sensing, mainly attributed to lower binding affinities of the nanobodies obtained from a single-round biopanning ( Figure 2 ). Tighter binders can be selected using more biopanning rounds; however, the detection of RBD, a monomeric protein target, serves to demonstrate the general feasibility of the Nano2RED co-binding assay in detection of a broad range of antigens, regardless of their complex molecular structures. Considering the fact that the spike protein is a trimer and each SARS-CoV-2 particle is covered with ~20 copies of such trimers 41 , the detection of SARS-CoV-2 virus particles could behave differently. The detection of SARS-CoV-2 particles might have a better sensitivity. The detection of viral particles from patient samples would itself be quite exciting future studies but beyond the scope of this work. Nevertheless, the broadband dynamic range (~100 fM to 1 µM for co-binders, or 7 logs), high sensitivity, high specificity, and broad applications therefore make our Nano2RED assay highly feasible for precise antigen quantification and detection of early-stage infection. We have demonstrated a generalizable and rapid assay design and pipeline that combines fast affinity reagent selection and production with nanometer-scale theoretical analysis and experimental characterization for optimized sensing performance. Synthetic, high-affinity, cobinding nanobodies, which could be quickly produced by a phage display selection method from a premade combinatorial library for any given antigen, proved to be effective in detecting dimeric Ebola sGP and monomeric SARS-CoV-2 RBD proteins. The Nano2RED utilized unique signal transduction pathways to convert biological binding into electronic readout. Using simple electronic circuitry, it starts with AuNP aggregation (governed by dynamic antigen-nanobody interactions described by Langmuir isotherm), which triggers AuNP cluster sedimentation (explained by Mason-Weaver equation 42 ), and then enables AuNP-concentration-dependent optical extinction (following Beer-Lambert law). The use of AuNPs for in-solution testing serves to greatly facilitate fluidic transport and antigen binding at nanometer scale. Nano2RED eliminates the need for long-time incubation due to slow analyte diffusion in conventional ELISA and other plane surface-based assays, as well as its associated cumbersome washing steps. The introduction of brief centrifugation and vortex mixing further greatly shortens the aggregation and sedimentation time, enabling rapid tests (within 5 to 20 min) without sacrificing sensitivity or specificity. Our data showed that Nano2RED is highly sensitive (sub-picomolar or ~10 pg/mL level for sGP) and specific in biological buffers while also affordable and accessible. Importantly, the portable electronic readout, despite being very simple and inexpensive (<$5), proved to be more reliable and sensitive than colorimetric and even spectrometric readout. Nano2RED can be applied for lab tests to detect early-stage virus infection at a high sensitivity potentially comparable to PCR. It can also be used for high-frequency at-home or in-clinic diagnostics, as well as in resource-limited regions, which could greatly enhance control of disease transmission. The digital data format will also reduce human intervention in data compiling and reporting, while facilitating fast and accessible data analysis. Nano2RED may find immediate use in the current COVID-19 pandemic for both antigen and antibody detection, as well as preparing for future unforeseeable new outbreaks. hours to remove the generated bubbles. The mixture was then poured into a flat plastic container at room temperature and incubated for one week, until the PDMS is fully cured. The PDMS membrane was then cut to rectangular shape, and 2 mm wells were drilled by punchers. To prevent non-specific bonding of proteins, the PDMS membrane was treated with PVA, adapted from methods described by Trantidou et al. 43 The as-prepared PDMS membrane and a diced rectangle shaped fused silica (500 µm thick) were both rinsed with isopropyl alcohol, dried in nitrogen, and The dark field scattering was illuminated by an xeon lamp, collected by a 100×dark field lens (NA=0.9), and imaged by an EMCCD camera. The integration time was set to 50 ms. For each drop-cast sample spot, ten images were taken from different areas in the spot. The size for the area taken in each dark-field scattering image was 62.5 μm×62.5 μm. SEM imaging of drop-cast samples on gold. The SEM image was taken by a Hitachi S4700 field emission scanning electron microscope at 5 kV acceleration voltage and magnification of 15,000. For each drop-cast sample spot, ten images were taken from different regions in the spot. (Table S1 and Figure S25 ). We noticed in our case that using and both yielded more consistent reporting of LOD compared to using , and therefore the sensor LOD was estimated with for its best consistency (Table 1) . This consistency could be attributed to the nature of our data collection is a physical process and less dependent on reagent concentration compared to conventional ELISA. Particularly when using spectrometric readout, the noise is strongly affected by optical focusing and could happen to any data sets; and therefore the overall average provides a better estimate of the empirical errors. Differently, for ELISA measurement, the sigma is much smaller at lower concentrations, so we used conventional for LOD determination. co-binders in biological buffers and analyzed the sensing performance. S. K. performed sGP and RBD co-binders screening. S. K. and Y. P. biochemically characterized co-binder candidates. Z. Z. performed initial sensing experiments to study spectroscopic readout in sGP detection. J. Z. contributed to the portable spectroscopic setup. L.G. conceived the idea of using synthetic nanobodies for antigen (sGP and RBD) detection and led the efforts in screening and characterization of nanobodies. C. W. conceived the idea of using NP for in-solution antigen assay, investigated the sensing mechanism, designed the incubation-based and rapid assay formats, led experiments to study the sGP and RBD sensing performance with colorimetric, spectrometric, and electronic readout. C.W. and L.G. coordinated this research project and wrote the manuscript together. Correspondence and requests for materials should be addressed to L.G. or C.W. RBD detection in 5% HPS buffer. (j-l) RBD detection in 5% WB buffer. Characterization and analytical validation of a new antigenic rapid diagnostic test for Ebola virus disease detection Ebola virus: unravelling pathogenesis to combat a deadly disease Diagnostic preparedness for infectious disease outbreaks Laboratory Diagnosis of COVID-19: Current Issues and Challenges SHERLOCK: nucleic acid detection with CRISPR nucleases Detection of SARS-CoV-2 with SHERLOCK One-Pot Testing Rethinking Covid-19 test sensitivity-A strategy for containment Diagnosis of Ebola Virus Disease: Past, Present, and Future Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres What Ebola tells us about outbreak diagnostic readiness Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis Nanobodies: natural single-domain antibodies. Annual review of biochemistry COMBINES-CID: An efficient method for de novo engineering of highly specific chemically induced protein dimerization systems The multiple roles of sGP in Ebola pathogenesis Towards detection and diagnosis of Ebola virus disease at point-of-care Ultrasensitive point-of-care immunoassay for secreted glycoprotein detects Ebola infection earlier than PCR Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2 A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2 COVID-19 vaccine design: the Janus face of immune enhancement Convergent antibody responses to SARS-CoV-2 in convalescent individuals Antibody affinity-III the role of multivalence Cooperative binding by mouse IgG3 antibodies: implications for functional affinity, effector function, and isotype restriction Why gold nanoparticles are more precious than pretty gold: noble metal surface plasmon resonance and its enhancement of the radiative and nonradiative properties of nanocrystals of different shapes Construction of simple gold nanoparticle aggregates with controlled plasmon-plasmon interactions UV-Vis and NMR study of the formation of gold nanoparticles by citrate reduction: Observation of gold-citrate aggregates A DNA-based method for rationally assembling nanoparticles into macroscopic materials Development of an aggregation-based immunoassay for anti-protein A using gold nanoparticles Spectral properties and relaxation dynamics of surface plasmon electronic oscillations in gold and silver nanodots and nanorods Shed GP of Ebola virus triggers immune activation and increased vascular permeability The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing Kinetics of antigen-antibody reactions at solid-liquid interfaces Smoluchowski's coagulation equation: probabilistic interpretation of solutions for constant, additive and multiplicative kernels Biophysical analysis of the interaction of human ifnar2 expressed in E. coli with IFNα2 Extracting kinetic rate constants from surface plasmon resonance array systems The sedimentation of colloidal nanoparticles in solution and its study using quantitative digital photography Ultrasensitive Ebola virus antigen sensing via 3D nanoantenna arrays A 2′ FY-RNA motif defines an aptamer for Ebolavirus secreted protein Structures and distributions of SARS-CoV-2 spike proteins on intact virions The settling of small particles in a fluid Hydrophilic surface modification of PDMS for droplet microfluidics using a simple, quick, and robust method via PVA deposition. Microsystems & nanoengineering The online version contains supplementary material available at XXX.